Gullapalli joins Amgen from Novartis where he led the development of their Global Center in Hyderabad

Amgen announced the appointment of Naveen Gullapalli as Managing Director of Amgen India. Gullapalli will lead the Amgen India Technology and Innovation site in Hyderabad leveraging his extensive experience leading global operations and adjoining functions across the pharmaceutical, finance and technology industries.

Gullapalli joins Amgen from Novartis where he led the development of their Global Center in Hyderabad and their network of six centres across the world where he was instrumental in driving strategic growth and innovation for the enterprise. His deep experience in developing specialised skills and enabling business transformation aligns closely with Amgen’s vision for its Hyderabad site as a global technology and innovation hub.

"We are thrilled to welcome Naveen to Amgen," said Som Chattopadhyay, national executive for India at Amgen. "Amgen India is key to furthering our global vision of unlocking the convergence of biotech and tech to accelerate innovation and help meet the needs of a globally aging population. Naveen’s wealth of experience and strategic leadership will drive the success of this new site.”

“India’s talent pool offers a compelling opportunity for Amgen to deliver world-class functional excellence, operational excellence, innovation and technology-led transformation,” said Naveen Gullapalli. “I am excited for this opportunity to advance tech from India to serve more patients globally,” he added.